These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 10338739)
1. How should managed care treat onychomycosis? Katz HI Am J Manag Care; 1998 Oct; 4(10):1471-9; quiz 1480-1. PubMed ID: 10338739 [TBL] [Abstract][Full Text] [Related]
2. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails. Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377 [TBL] [Abstract][Full Text] [Related]
3. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. Baran R; Kaoukhov A J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):21-9. PubMed ID: 15649187 [TBL] [Abstract][Full Text] [Related]
4. Therapies for onychomycosis: a review. Gupta AK; Tu LQ Dermatol Clin; 2006 Jul; 24(3):375-9. PubMed ID: 16798436 [TBL] [Abstract][Full Text] [Related]
6. [Therapy of nail mycoses]. Büchner SA Ther Umsch; 1998 Aug; 55(8):503-8. PubMed ID: 9757817 [TBL] [Abstract][Full Text] [Related]
7. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement. Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051 [TBL] [Abstract][Full Text] [Related]
8. Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US. Van Duyn Graham L; Elewski BE Mycoses; 2011 Nov; 54(6):e679-85. PubMed ID: 21668517 [TBL] [Abstract][Full Text] [Related]
9. The future of onychomycosis therapy may involve a combination of approaches. Hay RJ Br J Dermatol; 2001 Oct; 145 Suppl 60():3-8. PubMed ID: 11777262 [TBL] [Abstract][Full Text] [Related]
10. Management of onychomycosis: examining the role of monotherapy and dual, triple, or quadruple therapies. Gupta AK; Lynch LE Cutis; 2004 Jul; 74(1 Suppl):5-9. PubMed ID: 15287394 [TBL] [Abstract][Full Text] [Related]
13. Fungal nail infections: diagnosis and management. Prescrire Int; 2009 Feb; 18(99):26-30. PubMed ID: 19391293 [TBL] [Abstract][Full Text] [Related]
14. Treatment of onychomycosis with oral antifungal agents. Iorizzo M; Piraccini BM; Rech G; Tosti A Expert Opin Drug Deliv; 2005 May; 2(3):435-40. PubMed ID: 16296765 [TBL] [Abstract][Full Text] [Related]
15. Which antifungal agent for onychomycosis? A pharmacoeconomic analysis. Joish VN; Armstrong EP Pharmacoeconomics; 2001; 19(10):983-1002. PubMed ID: 11735669 [TBL] [Abstract][Full Text] [Related]
16. The new oral antifungal agents for onychomycosis of the toenails. Gupta AK; Shear NH J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624 [TBL] [Abstract][Full Text] [Related]
17. Management of onychomycosis with topicals. Albert SF; Weis ZH Clin Podiatr Med Surg; 2004 Oct; 21(4):605-15, vii. PubMed ID: 15450900 [TBL] [Abstract][Full Text] [Related]
18. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine. Angello JT; Voytovich RM; Jan SA Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095 [TBL] [Abstract][Full Text] [Related]